Table 1. Patients’ characteristics and outcome.
| Age (Years) | Tumor site | T stage | Histotype | Disease free* | Outcome |
|---|---|---|---|---|---|
| 8 1/2 | Left foreleg | T3 | PWT Grade II | 483 | NED |
| 13 | Right foreleg | T3 | U-SA | 93 | Recurrence, euthanasia |
| 2 1/2 | Right hindleg | T2 | HSA | 1053 | NED |
| 9 | Head | T3 | PNST Grade II | 1505 | NED |
| 8 | Thorax | T3 | FSA Grade II | 1249 | NED |
| 9 | Right foreleg | T2 | PWT Grade I | 1298 | NED |
| 10 | Left foreleg | T2 | PWT Grade II | 1235 | NED |
| 3 | Right foreleg | T3 | U-SA | 366 | Recurrence, amputation |
| 4 | Abdomen | T3 | CSA | 856 | Dead, renal failure |
| 10 | Lumbar | T3 | PWT Grade II | 840 | NED |
| 10 1/2 | Head | T2 | HSA | 366 | Recurrence,metastasis |
| 10 | Right hindleg | T3 | LipoSA | 443 | Recurrence, amputation |
| 8 | Left hindleg | T3 | PWT Grade II | 692 | NED |
| 6 | Right foreleg | T2 | PWT Grade II | 660 | NED |
| 14 | Thorax | T3 | PNST Grade II | 413 | Dead, cardiac disease |
| 4 | Flank | T3 | LipoSA | 604 | NED |
| 6 | Flank | T3 | FSA Grade II | 574 | NED |
| 13 1/2 | Head | T2 | CSA | 513 | NED |
| 10 | Left hindleg | T2 | PWT Grade II | 370 | NED |
| 13 | Perineum | T2 | FSA Grade II | 370 | NED |
| 7 | Perineum | T3 | FSA Grade II | 338 | NED |
| 8 | Flank | T3 | CSA | 286 | NED |
| 10 | Right foreleg | T3 | PNST Grade III | 283 | NED |
| 11 | Left foreleg | T2 | PNST Grade II | 269 | NED |
| 10 | Abdomen | T3 | PNST Grade II | 584 | NED |
| 3 | Flank | T3 | FSA Grade II | 212 | NED |
| 6 | Right foreleg | T2 | PWT Grade II | 209 | NED |
| 5 | Left foreleg | T2 | FSA Grade II | 209 | NED |
| 8 | Right foreleg | T2 | PWT Grade II | 205 | NED |
| 8 | Flank | T3 | PNST Grade II | 149 | NED |
(PWT): perivascular wall tumor; (U-SA): undifferentiated sarcoma; (HSA): hemangiosarcoma; (PNST): peripheral nerve sheat tumor; (FSA): fibrosarcoma; (CSA): chondrosarcoma; (LipoSA): liposarcoma; (NED): no evidence of disease; (*): Days.